The Importance of Partnership in the Rollout of Triple-Drug Therapy to Eliminate Lymphatic Filariasis in the Pacific.
Am J Trop Med Hyg
; 106(5_Suppl): 39-47, 2022 05 11.
Article
en En
| MEDLINE
| ID: mdl-35292579
ABSTRACT
We discuss the experience of some Pacific island countries in introducing the new WHO-recommended treatment protocol for lymphatic filariasis-a triple-drug therapy composed of ivermectin, diethylcarbamazine, and albendazole. The successful rollout of the new treatment protocol was dependent on strong partnerships among these countries' ministries of health, WHO, and other stakeholders. Effective communication among these partners allowed for lessons learned to cross borders and have a positive impact on the experiences of other countries. We also describe various challenges confronted during this process and the ways these countries overcame them.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Filariasis Linfática
/
Filaricidas
Tipo de estudio:
Guideline
Límite:
Humans
Idioma:
En
Revista:
Am J Trop Med Hyg
Año:
2022
Tipo del documento:
Article
País de afiliación:
Fidji